Skip to main content
. 2016 Oct 5;43(10):1146–1153. doi: 10.1111/1346-8138.13338

Figure 2.

Figure 2

Overall study flow. Two patients discontinued in the induction phase because of dose‐limiting toxicity (DLT). Four patients discontinued in the maintenance phase by adverse events or distant metastasis. Treatment was ongoing at approval in three patients. ALT, alanine aminotransferase; AST, aspartate aminotransferase.